Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain

NCT00411268 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Back Pain

Interventions

DRUG: OROS hydromorphone HCI SR (slow release)

Sponsor

Alza Corporation, DE, USA